Alnylam Pharmaceuticals
ALNY
#564
Rank
โ‚ฌ36.43 B
Marketcap
274,76ย โ‚ฌ
Share price
-1.75%
Change (1 day)
23.03%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company